NCT07211607View on ClinicalTrials.gov

I.V. Selonabant in Healthy Adult Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

August 25, 2026

Study Completion Date

August 25, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

selonabant

Intravenous infusion of selonabant

DRUG

placebo

Placebo infusion which looks the same as the selonabant infusion

Trial Locations (1)

78744

RECRUITING

PPD Austin Clinical Research Unit, Austin

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Anebulo Pharmaceuticals

INDUSTRY

NCT07211607 - I.V. Selonabant in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter